The relationship between type 2 diabetes and cognitive dysfunction: Longitudinal studies and their methodological limitations

European Journal of Pharmacology

Volumn 490, Issue 1-3, 2004, Pages 169-175

  Allen, Kate V ^a   Frier, Brian M ^a   Strachan, Mark W J ^b  

^a ROYAL INFIRMARY OF EDINBURGH   (United Kingdom)

^b WESTERN GENERAL HOSPITAL   (United Kingdom)

Author keywords

Alzheimer's disease; Cognition; Dementia; Diabetes

Indexed keywords

INSULIN;

ALZHEIMER DISEASE; ARTICLE; CASE CONTROL STUDY; COGNITIVE DEFECT; DISEASE ASSOCIATION; FOLLOW UP; HUMAN; INFORMATION RETRIEVAL; INTERMETHOD COMPARISON; MEDICAL ASSESSMENT; MEDICAL LITERATURE; NON INSULIN DEPENDENT DIABETES MELLITUS; POPULATION RESEARCH; PRIORITY JOURNAL; PSYCHOLOGIC ASSESSMENT; RISK ASSESSMENT; RISK FACTOR; UTILIZATION REVIEW;

COGNITION DISORDERS; DEMENTIA; DIABETES MELLITUS, TYPE 2; HUMANS; LONGITUDINAL STUDIES; NEUROPSYCHOLOGICAL TESTS; REPRODUCIBILITY OF RESULTS;

EID: 1842633820     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejphar.2004.02.054     Document Type: Article

References (61)

1. American Psychiatric Association Diagnostic and Statistical Manual of Mental Disorders, Third edition (DSM-III). 1980;. Washington, DC.
2. American Psychiatric Association Diagnostic and Statistical Manual of Mental Disorders, Fourth edition (DSM-IV). 1994;. Washington, DC.
3. Anderson R.J., Freedland K.E., Clouse R.E., Lustman P.J. The prevalence of comorbid depression in adults with diabetes. Diabetes Care. 24:2001;1069-1078.
4. Areosa Sastre A., Grimley Evans J. Effect of the treatment of type II diabetes mellitus on the development of cognitive impairment and dementia (Cochrane Review). The Cochrane Library, issue 2. 2003;1-24 Update Software, Oxford.
5. Asimakopoulou K.G., Hampson S.E., Morrish N.J. Neuropsychological functioning in older people with type 2 diabetes: the effect of controlling for confounding factors. Diabet. Med. 19:2002;311-316.
6. Austin M.P., Mitchell P. The anatomy of melancholia: does fronto-cortical pathophysiology underpin its psychomotor and cognitive manifestations? Psychol. Med. 25:1997;665-672.
7. Carmelli D., Swan G.E., Reed T., Miller B., Wolf P.A., Jarvik G.P., Schellenberg G.D. Midlife cardiovascular risk factors, ApoE, and cognitive decline in elderly male twins. Neurology. 50:1998;1580-1585.
8. Colsher P.L., Wallace R.B. Epidemiologic considerations in studies of cognitive function in the elderly: methodology and nondementing acquired dysfunction. Epidemiol. Rev. 13:1991;1-27.
9. Cosway R., Strachan M.W., Dougall A., Frier B.M., Deary I.J. Cognitive function and information processing in type 2 diabetes. Diabet. Med. 18:2001;803-810.
10. Croxson S.C.M., Jagger C. Diabetes and cognitive impairment: a community-based study of elderly subjects of elderly subjects. Age and Ageing. 24:1995;421-424.
11. Deary I.J. Effects of hypoglycaemia on cognitive function. Frier B.M., Fisher B.M. Hypoglycaemia and Diabetes: Clinical and Physiological Aspects. 1993;80-92 Edward Arnold, London.
12. Elias M.F., Wolf P.A., D'Agostino R.B., Cobb J., White L.R. Untreated blood pressure level is inversely related to cognitive functioning: the Framingham study. Am. J. Epidemiol. 138:1993;353-364.
13. Elias P.K., Elias M.F., D'Agostino R.B., Cupples L.A., Wilson P.W., Silbershatz H., Wolf P.A. NIDDM and blood pressure as risk factors for poor cognitive performance. Diabetes Care. 20:1997;1388-1395.
14. Evans D.A., Funkenstein H.H., Albert M.S., Scherr P.A., Cook N.R., Chown H.J., Hebert L.E., Hennekens C.H., Taylor J.O. Prevalence of Alzheimer's disease in a community population of older persons: higher than previously reported. J. Am. Med. Assoc. 262:1989;2551-2556.
15. Ferguson S.C., Blane A., Perros P., McCrimmon R.J., Best J.J.K., Wardlaw J., Deary I.J., Frier B.M. Cognitive ability and brain structure in type 1 diabetes: relation to microangiopathy and preceding severe hypoglycemia. Diabetes. 52:2003;149-156.
16. Folstein M.F., Folstein S.E., McHugh P.R. Mini-Mental State. A practical method for grading the cognitive state of patients for the clinician. J. Psychiatr. Res. 12:1975;189-198.
17. Fontbonne A., Berr C., Ducimetiere P.D., Alperovitch A. Changes in cognitive abilities over a 4 year period are unfavourably affected in elderly diabetic subjects. Diabetes Care. 24:2001;366-370.
18. Franse L., Di Bai M., Shorr R.I., Resnik H.E., Van Eijk J.T., Bauer D.C., Newman A.B., Pahor M. Type 2 diabetes in older well-functioning people: who is undiagnosed? Diabetes Care. 24:2001;2065-2070.
19. Geldmacher D.S., Whitehouse P.J. Evaluation of dementia. N. Engl. J. Med. 335:1996;330-336.
20. Gradman T.J., Laws A., Thompson L.W., Reaven G.M. Verbal learning and/or memory improves with glycemic control in older subjects with non-insulin-dependent diabetes mellitus. J. Am. Geriatr. Soc. 41:1993;1305-1312.
21. Greenwood C.E., Kaplan R.J., Hebblethwaite S., Jenkins D.J.A. Carbohydrate-induced memory impairment in adults with type 2 diabetes. Diabetes Care. 26:2003;1961-1966.
22. Gregg E.W., Yaffe K., Cauley J.A., Rolka D.B., Blackwell T.L., Narayan V., Cummings S.R. Is diabetes associated with cognitive impairment and cognitive decline among older women? Arch. Int. Med. 160:2000;174-180.
23. Haan M.N., Shemanski L., Jagust W.J., Manolio T.A., Kuller L. The role of APOE ε4 in modulating effects of other risk factors for cognitive decline in elderly persons. J. Am. Med. Assoc. 282:1999;40-46.
24. Harris M.I. Undiagnosed NIDDM: clinical and public health issues. Diabet. Care. 16:1993;642-652.
25. Harris M.I. Diabetes in America: epidemiology and scope of the problem. Diabetes Care. 21(Suppl. 3):1998;C11-C14.
26. Harris M.I., Klein R., Welborn T.A., Knuiman M.W. Onset of NIDDM occurs at least 4-7yr before clinical diagnosis. Diabetes Care. 15:1992;815-819.
27. Harris M.I., Flegal K.M., Cowie C.C., Eberhardt M.S., Goldstein D.E., Little R.R., Wiedmeyer H.-M., Byrd-Holt D.D. Prevalence of diabetes, impaired fasting glucose, and impaired glucose tolerance in US adults: the third National Health and Nutrition Examination Survey, 1988-1994. Diabetes Care. 21:1998;518-524.
28. Helkala E.L., Niskansen L., Viinamaki H., Partanen J., Uusitups M. Short-term and long-term memory in elderly patients with NIDDM. Diabetes Care. 18:1995;681-685.
29. Hofman A., Ott A., Breteler M.M.B., Bots M.L., Slooter A.J.C., van Harskamp F., van Duijn C.N., Van Broeckhoven C., Grobbee D.E. Atherosclerosis, apolipoprotein E, and prevalence of dementia and Alzheimer's disease in the Rotterdam study. Lancet. 349:1997;151-154.
30. Kalmijn S., Feskens E.J.M., Launer L.J., Kromhout D. Cerebrovascular diasease, the apolipoprotein ε4 allele, and cognitive decline in a community-based study of elderly men. Stroke. 27:1996;2230-2235.
31. Knopman D., Boland L.L., Mosley T., Howard G., Liao D., Szklo M., McGovern P., Folsom A.R. Cardiovascular risk factors and cognitive decline in middle aged adults. Neurology. 56:2001;42-48.
32. Launer L.J., Masaki K., Petrovitch H., Foley D., Havlik R.J. The association between midlife blood pressure levels and late-life cognitive function. The Honolulu-Asia Aging Study. J. Am. Med. Assoc. 274:1995;1846-1851.
33. Launer L.J., Feskens E.J.M., Kalmijn S., Kromhout D. Smoking, drinking and thinking: the zutphen elderly study. Am. J. Epidemiol. 143:1996;219-227.
34. Luchsinger J.A., Tang M.X., Stern Y., Shea S., Mayeux R. Diabetes mellitus and risk of Alzheimer's disease and dementia with stroke in a multiethnic cohort. Am. J. Epidemiol. 154:2001;635-641.
35. MacKnight C., Rockwood K., Awalt E., McDowell I. Diabetes treatment and the risk of dementia, Alzheimer's disease and vascular cognitive impairment in the Canadian study of health and aging. Dement. Geriatr. Cogn. Disord. 14:2002;77-83.
36. McKhann G., Drachman D., Folstein M., Katzman R., Price D., Stadlan E.M. Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA work group under the auspices of department of health and human services task force on Alzheimer's disease. Neurology. 34:1984;939-944.
37. Meneilly G.S., Cheung E., Tessier D., Yakura C., Tuokko H. The effect of improved glycemic control on cognitive functions in the elderly patient with diabetes. J. Gerontol. 1993;M117-M121.
38. Miles W.R., Root H.F. Psychologic tests applied to diabetic patients. Arch. Int. Med. 30:1922;767-777.
39. Morris M.C., Evans D.A., Hebert L.E., Bienias J.L. Methodological issues in the study of cognitive decline. Am. J. Epidemiol. 149:1999;789-793.
40. Naor M., Steingruber H.J., Westhoff K., Schottenfeld-Naor Y., Gries A.F. Cognitive function in elderly non-insulin-dependent diabetic patients before and after inpatient treatment for metabolic control. J. Diabetes Complicat. 11:1997;40-46.
41. Noguchi S., Murakami K., Yamada N. Apolipoprotein E genotype and Alzheimer's disease. Lancet. 342:1993;737. (letter).
42. Ott A., Stolk R.P., van Harskamp F., Pols H.A.P., Hofman A., Breteler M.M.B. Diabetes mellitus and the risk of dementia: the Rotterdam study. Neurology. 53:1999;1937-1942.
43. Peila R., Rodriguez B.L., Launer L.J. Type 2 diabetes, APOE gene, and the risk for dementia and related pathologies: the Honolulu-Asia aging study. Diabetes. 51:2002;1256-1262.
44. Perros P., Deary I.J. Long-term effects of hypoglycaemia on cognitive function and the brain in diabetes. Frier B.M., Fisher B.M. Hypoglycaemia in Clinical Diabetes. 1999;187-210 Wiley, Chichester.
45. Petersen R.C., Stevens J.C., Ganguli M., Tangalos E.G., Cummings J.L., DeKosky S.T. Early detection of dementia: mild cognitive impairment (an evidence based review). Neurology. 56:2001;1133-1142.
46. Reding M., Haycox J., Blass J. Depression in patients referred to a dementia clinic: a three year prospective study. Arch. Neurol. 42:1985;894-896.
47. Robertson-Tchabo E.A., Arenberg D., Tobin J.D., Plotz J.B. A longitudinal study of cognitive performance in noninsulin dependent (type II) diabetic men. Exp. Gerontol. 21:1986;459-467.
48. Roman G.C., Tatemachi T.K., Erkinjuntti T., Cummings J.L., Masdeu J.C., Garcia J.H., Amaducci L., Orgogozo J.M., Brun A., Hofman A.et al. Vascular dementia: diagnostic criteria for research studies. Report of the NINDS-AIREN International Workshop. Neurology. 43:1993;250-260.
49. Ryan C.M., Geckle M.O., Orchard T.J. Cognitive efficiency declines over time in adults with type 1 diabetes: effects of micro-and macrovascular complications. Diabetologia. 46:2003;940-948.
50. Small S.A., Stern Y., Tang M., Mayeux R. Selective decline in memory function among healthy elderly. Neurology. 52:1999;1392-1396.
51. Sommerfield A.J., Deary I.J., Frier B.M. Acute hyperglycaemia alters mood state and impairs cognitive performance in people with type 2 diabetes. Diabet. Med. 20(Suppl. 2):2003;31. (abstract).
52. Sotaniemi E.A., Haapakoski E., Rautio A. Ginseng therapy in non-insulin dependent diabetic patients: effects on psychophysical performance, glucose homeostasis, serum lipids, serum aminoterminalpropeptide concentration, and body weight. Diabetes Care. 18:1995;1373-1375.
53. Stewart R., Liolitsa D. Type 2 diabetes mellitus, cognitive impairment and dementia. Diabet. Med. 16:1999;93-112.
54. Strachan M.W.J., Deary I.J., Ewing F.M.E., Frier B.M. Is type 2 diabetes associated with an increased risk of cognitive dysfunction? Diabetes Care. 20:1997;438-445.
55. Strachan M.W., Frier B.M., Deary I.J. Cognitive assessment in diabetes: the need for consensus. Diabet. Med. 14:1997;421-422.
56. Swainson R., Hodges J.R., Galton C.J., Semple J., Michael A., Dunn B.D., Iddon J.L., Anderson R.J., Freeedland K.E., Clouse R.E., Lustman P.J. The prevalence of comorbid depression in adults with diabetes. Diabetes Care. 24:2001;1069-1078.
57. Teng E.L., Chui H.C. The Modified Mini-Mental State (3MS) examination. J. Clin. Psychiatry. 48:1987;314-318.
58. Tombaugh T.N., McIntyre N.J. The Mini-Mental State Examination: a comprehensive review. J. Am. Geriatr. Soc. 40:1992;922-935.
59. Uusitupa M.I.J., Karhunen L., Rissanen A., Fransilla-Kaluncki A., Niskanen L., Kervinen K., Kesaniemi Y.A. Apolipoprotein E phenotype modifies metabolic and hemodynamic abnormalities related to central obesity in women. Am. J. Clin. Nutr. 64:1996;131-136.
60. Visser P.J., Verhey F., Ponds R., Kester A., Jolles J. Distinction between preclinical Alzheimer's disease and depression. J. Am. Geriat. Soc. 48:2000;479-484.
61. Yoshitake T., Kiyohara Y., Kato I., Ohmura T., Iwamoto H., Nakayama K., Ohmori S., Nomiyama K., Kawano H., Ueda K., Sueshi K., Tsuneyoshi M., Fujishima M. Incidence and risk factors of vascular dementia and Alzheimer's disease in a defined elderly Japanese population: the Hisayama study. Neurology. 45:1995;1161-1168.